DEANNA CLEMONS: Open Payments
NPI 1992748891 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 23 payments from 7 companies in 2025. Trend: 2023 $1,026 · 2024 $1,304 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $154 |
| Novo Nordisk Inc | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Amgen Inc. | 3 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| ABIOMED | 1 | $15 |
Products named: OPTIS, Wegovy, LEQVIO, REPATHA, AMVUTTRA, CAMZYOS, NAVITOR.
Industry payments across AL — which companies pay providers there.
